Parliament’s First Reading of the Tobacco Control Bill, 2025 (N.A.B. 40 of 2025) may appear procedural. It is anything but. It marks a decisive shift in Zambia’s public health architecture one that places the right to health and protection from this rights’ abuses above the commercial interests of an industry whose products, by design, entice, addict and cause death.
This Bill is not incremental reform. It is structural reform.
At its heart, the legislation seeks to protect present and future generations from the devastating health, social, environmental and economic consequences of tobacco use, nicotine addiction and exposure to harmful emissions. Notably, it extends beyond conventional cigarettes to regulate tobacco devices and nicotine products, including new and emerging alternatives that are often marketed as “innovative” or “reduced harm or in the cunning circumstance “FCTC compliant.” The message is clear: the delivery mechanism may evolve, but addiction remains the business model.
One of the most consequential features of the Bill is its protection of public policy from tobacco industry interference. It limits interactions between Government and the tobacco industry to what is strictly necessary for regulation and requires transparency in such engagements. It also establishes strict conflict-of-interest provisions for public officials. This is not symbolic. Globally, tobacco industry interference has been one of the most persistent barriers to effective tobacco control. By codifying safeguards, Zambia aligns itself with the core obligations of the WHO Framework Convention on Tobacco Control (FCTC), which it ratified.
The Bill also creates a Tobacco Control Committee with multi-sectoral representation—from health and finance to commerce, education, environment and youth. This is a recognition that tobacco control is not solely a health issue; it is a fiscal, developmental and governance issue. Tobacco-related illness burdens the health system, reduces workforce productivity and undermines long-term economic growth. Intricately, the bill is not a Ministry of Health issue; it is a Government Issue.
Regulation of manufacture, distribution, import and export through a licensing and permit regime introduces accountability into a sector long characterized by opacity. Industry actors frequently argue that stronger regulation fuels illicit trade. The evidence suggests the opposite: weak oversight creates the conditions for illicit markets to thrive. Licensing, reporting requirements and traceability strengthen compliance and enforcement.
The bill’s packaging and labelling provisions are equally robust. Graphic health warnings covering a substantial proportion of principal display areas, rotation of warnings, and prohibitions on misleading descriptors such as “light,” “mild,” or “natural” are designed to counter decades of deceptive marketing. Courts in multiple jurisdictions have affirmed that such measures do not violate intellectual property rights. A brand’s commercial expression does not trump a population’s right to accurate health information.
Comprehensive smoke-free provisions protect citizens from involuntary exposure in enclosed workplaces, public places and public conveyances, as well as specified outdoor areas. This is not an intrusion into personal liberty. It is an affirmation of a fundamental principle: one person’s consumption cannot compromise another person’s health.
Perhaps most significantly, the Bill imposes a near-total ban on advertising, promotion and sponsorship, including indirect forms such as brand stretching, product placement, and corporate social responsibility initiatives that function as reputational shields. The industry often insists that advertising merely affects brand choice. Yet global evidence consistently demonstrates that marketing increases youth initiation and normalises consumption. Removing the promotional ecosystem reduces uptake.
Predictably, economic alarm bells are being rung. Jobs. Farmers. Revenue. These claims warrant scrutiny. The Bill explicitly allows Government to promote economically viable alternatives for tobacco growers and others in the supply chain. Moreover, the economic costs of tobacco-related disease—healthcare expenditure, lost productivity and premature mortality—far exceed the fiscal contributions of the industry. Tobacco is not a net economic asset when its full cost is accounted for.
The Tobacco Control Bill of 2025 does not criminalise smokers. It regulates a powerful industry and sets guardrails around a product category that carries profound public health risks. It modernizes Zambia’s regulatory framework in line with global best practice and closes long-standing loopholes that have allowed aggressive marketing and policy interference.
This is a generational decision point. Countries that have adopted comprehensive tobacco control frameworks have seen declines in smoking prevalence, reductions in disease burden and strengthened public health outcomes. Those that hesitate often find themselves managing escalating health costs and entrenched industry influence.
The first Reading is only the beginning. As the Bill progresses through Parliament, debate will intensify. It should. Robust scrutiny strengthens legislation. But the central question must remain: whose interests are being protected? And at what cost?
In choosing to act decisively, Zambia signals that the health of its people is not negotiable. That is not radical. It is responsible governance. The line has been drawn. The choice now is whether to hold it.
In Part II of this article, we will move beyond the architecture of the Bill to examine its practical implications. We will interrogate the economic arguments more rigorously—jobs, farmers, revenue and illicit trade—using evidence rather than rhetoric. We will also assess Zambia’s preparedness for enforcement, the fiscal dimensions of tobacco taxation, and what successful implementation would mean for public health, domestic resource mobilisation and long-term development. The debate now shifts from whether reform is necessary to how effectively it will be delivered.
About the Authors
Natalie Mwila is a development economist specializing in public policy, advocacy, and economic research. She serves as the Head of Advocacy at the Centre for Trade Policy and Development. She holds a bachelor’s degree in development studies from the University of Zambia and a master’s degree in economics and finance. She is currently studying a second master’s degree in data literacy at the University of St. Andrews in Scotland as a commonwealth scholar, with additional studies in sustainable development and the law at the University of Cambridge.
Robert Mwale serves as Lead Public Finance Researcher at the Centre for Trade Policy and Development (CTPD). He also serves as Coordinator for the Zambia Civil Society Organization Debt Alliance (CSO DA) as well as Coordinator for the Zambia Tax Platform (ZTP). He holds a bachelor’s degree in economics from the University of Zambia (UNZA), A Master of Science in economics from the Copperbelt University as well as a Master of Science in Financial Services from ZCAS University. He also has qualifications and competency in Investment Advisor and Stockbrokers Course.
